interferon beta-1a at a glance
Medicine class
Immunomodulating type I interferon
Main role
Disease-modifying treatment for relapsing multiple sclerosis
Administration
Intramuscular injection using a single-use pre-filled pen after training
Storage
Refrigerate, protect from light and do not freeze. Room-temperature storage is permitted only under the product information’s conditions.
What is interferon beta-1a used for?
The selected product is licensed for adults with:
Relapsing multiple sclerosis without continuous progression between relapses.
A single active inflammatory demyelinating event requiring intravenous corticosteroids, after excluding alternative diagnoses, when the person is at high risk of clinically definite multiple sclerosis.
How does interferon beta-1a work?
It binds to interferon receptors and activates interferon-responsive genes. The resulting immune-modulating effects are thought to reduce inflammatory attacks on myelin, although its precise therapeutic mechanism is uncertain.
interferon beta-1a preparations and strengths
Injection
Route: Parenteral
Strengths: 30 micrograms/0.5 mL
How to take interferon beta-1a
Use the pre-filled pen only after injection training and follow its package instructions. Inject into the upper outer thigh muscle, rotate injection sites and use aseptic technique.
Let the refrigerated pen reach room temperature naturally; do not use an external heat source.
Do not use a damaged pen, a pen with a broken seal, or a solution that is coloured or contains particles.
The pen is single-use. Dispose of it and the needle as instructed.
Request a technique review if handling is difficult or injection-site reactions occur.
interferon beta-1a side effects
Common or expected effects
- Flu-like symptoms such as fever, chills, sweating, headache, muscle aches, nausea and weakness, often more noticeable early in treatment.
- Injection-site pain, redness or bruising.
- Fatigue, sleep difficulty or depression.
- Nausea, vomiting, diarrhoea or reduced appetite.
- Muscle, joint or limb pain, stiffness or cramps.
- Changes in blood-cell counts or liver-function tests.
Get urgent medical advice
- Severe allergic reaction, including facial or tongue swelling and breathing difficulty.
- Severe depression, suicidal thoughts, psychosis or marked behavioural change.
- Liver injury, with possible jaundice, widespread itching, vomiting or easy bruising.
- Thrombotic microangiopathy, with possible fever, severe weakness, neurological symptoms, bruising, bleeding or kidney impairment.
- Nephrotic syndrome, with possible foamy urine, swelling and weight gain.
- Severe injection-site damage, particularly broken skin, swelling or fluid discharge.
- New or worsening heart failure symptoms or unexplained breathing difficulty.
interferon beta-1a in pregnancy
Interferon beta may be used during pregnancy when recommended by a specialist. Human data have not shown increased major congenital anomalies after exposure before conception or during the first trimester, but later-pregnancy experience is more limited. Discuss treatment and pregnancy plans with the MS and maternity teams.
interferon beta-1a while breastfeeding
The selected product can be used while breastfeeding. Transfer into milk is expected to be negligible and harmful effects in the infant are not anticipated; discuss individual circumstances with the specialist team.
interferon beta-1a interactions
Formal human interaction studies are limited. Review prescribed, over-the-counter and complementary products with the clinical team.
Narrow-therapeutic-index medicines cleared by hepatic cytochrome P450, including some antiepileptics and antidepressants
Interferons may reduce hepatic enzyme activity, so additional clinical or concentration monitoring may be appropriate.
Medicines associated with liver injury and alcohol
Potential additive liver toxicity warrants caution and monitoring.
Common questions about interferon beta-1a
Answers are fully visible for fast scanning and source review.
Can interferon beta-1a cure multiple sclerosis?
No. It can reduce relapses and slow disability progression in appropriate relapsing disease, but it does not cure multiple sclerosis.
Is interferon beta-1a an immunosuppressant?
It is described as an immunomodulator because it changes immune signalling rather than broadly suppressing all immune activity.
Can it briefly worsen neurological symptoms after an injection?
Yes. Temporary neurological symptoms, muscle tightness or weakness can resemble a relapse. New, severe or persistent symptoms need clinical assessment.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.